Using a clinical judgement model to understand the impact of validated pain assessment tools for burn clinicians and adult patients in the ICU: A multi-methods study.


Journal

Burns : journal of the International Society for Burn Injuries
ISSN: 1879-1409
Titre abrégé: Burns
Pays: Netherlands
ID NLM: 8913178

Informations de publication

Date de publication:
02 2021
Historique:
received: 21 02 2020
revised: 14 05 2020
accepted: 30 05 2020
pubmed: 6 12 2020
medline: 9 11 2021
entrez: 5 12 2020
Statut: ppublish

Résumé

Intensive care (ICU) patients' burn pain is difficult to assess, communicate and address, risking chronic pain syndromes and psychological morbidity. To understand how the introduction of validated pain tools (Critical Care Pain Observation Tool [CPOT], Numerical Rating Scale [NRS], Pain Assessment in Advanced Dementia [PAINAD]) affected clinical judgement processes, analgesia/sedation administration and the experience of burn-injured patients. Consecutive chart review compared type and amount of analgesia/sedation administered, ventilation time and length of ICU/hospital stay between consecutive burn patients pre- and 6-months post-intervention (n=70). Analysis of 36 qualitative interviews with ICU clinicians (n=12) and burn-injured adults (n=12) pre- and post-intervention was guided by Tanner's (2006) Clinical Judgement Model. Overall, there was a significant increase in morphine (P=0.04) and propofol (P=0.04) use and a trend towards increased paracetamol (P=0.06) use post-intervention. There was a trend towards greater Midazolam use for TBSA<20% (P=0.06), and significantly increased propofol use for TBSA≥20% (P=0.03). Ventilation time and ICU/hospital length of stay were unchanged. Qualitative analysis revealed complex clinical judgement dependent on the context of the patient's situation, unit culture, background beliefs of clinicians and in knowing the patient. Whilst the CPOT and NRS enhanced analytic reasoning and pain advocacy, the PAINAD appeared redundant. Effective pain assessment, management and advocacy are assisted by evidence-based assessment practices.

Sections du résumé

BACKGROUND
Intensive care (ICU) patients' burn pain is difficult to assess, communicate and address, risking chronic pain syndromes and psychological morbidity.
AIMS
To understand how the introduction of validated pain tools (Critical Care Pain Observation Tool [CPOT], Numerical Rating Scale [NRS], Pain Assessment in Advanced Dementia [PAINAD]) affected clinical judgement processes, analgesia/sedation administration and the experience of burn-injured patients.
METHODS
Consecutive chart review compared type and amount of analgesia/sedation administered, ventilation time and length of ICU/hospital stay between consecutive burn patients pre- and 6-months post-intervention (n=70). Analysis of 36 qualitative interviews with ICU clinicians (n=12) and burn-injured adults (n=12) pre- and post-intervention was guided by Tanner's (2006) Clinical Judgement Model.
RESULTS
Overall, there was a significant increase in morphine (P=0.04) and propofol (P=0.04) use and a trend towards increased paracetamol (P=0.06) use post-intervention. There was a trend towards greater Midazolam use for TBSA<20% (P=0.06), and significantly increased propofol use for TBSA≥20% (P=0.03). Ventilation time and ICU/hospital length of stay were unchanged. Qualitative analysis revealed complex clinical judgement dependent on the context of the patient's situation, unit culture, background beliefs of clinicians and in knowing the patient. Whilst the CPOT and NRS enhanced analytic reasoning and pain advocacy, the PAINAD appeared redundant.
CONCLUSIONS
Effective pain assessment, management and advocacy are assisted by evidence-based assessment practices.

Identifiants

pubmed: 33277094
pii: S0305-4179(20)30417-4
doi: 10.1016/j.burns.2020.05.032
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110-126

Informations de copyright

Copyright © 2020 Elsevier Ltd and ISBI. All rights reserved.

Auteurs

Susan Taggart (S)

Burns Unit, Concord Repatriation General Hospital, Hospital Road, CONCORD WEST, NSW 2139, Australia. Electronic address: susan.taggart@health.nsw.gov.au.

Katina Skylas (K)

Intensive Care Unit, Concord Repatriation General Hospital, Hospital Road, CONCORD WEST, NSW 2139, Australia. Electronic address: katina.skylas@health.nsw.gov.au.

Alison Brannelly (A)

Intensive Care Unit, Concord Repatriation General Hospital, Hospital Road, CONCORD WEST, NSW 2139, Australia. Electronic address: alison.brannelly@health.nsw.gov.au.

Greg Fairbrother (G)

Sydney Research, Sydney Local Health District, Level 11 KGV Building, Missenden Rd, CAMPERDOWN, NSW 2050, Australia; Susan Wakil School of Nursing & Midwifery, Faculty of Medicine & Health, University of Sydney, NSW 2006, Australia. Electronic address: greg.fairbrother@health.nsw.gov.au.

Mark Knapp (M)

Intensive Care Unit, Concord Repatriation General Hospital, Hospital Road, CONCORD WEST, NSW 2139, Australia. Electronic address: mark.knapp@health.nsw.gov.au.

Janice Gullick (J)

Susan Wakil School of Nursing & Midwifery, Faculty of Medicine & Health, University of Sydney, NSW 2006, Australia. Electronic address: janice.gullick@sydney.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH